Full name
PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA SPÓŁKA AKCYJNA
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
35.30.Z - Generation and supply of steam and air for air-conditioning systems
36.00.Z - Extraction, treatment, and supply of water
68.20.Z - Rental and management of own or leased real estate
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 1054,7 | 1178,2 | 1157,2 | -1,8 |
Gross profit (loss) | 90,4 | 126,6 | -8,6 | -106,8 |
Net profit (loss) | 84,9 | 118,3 | -16,5 | -113,9 |
Cash | 81,3 | 16,5 | 19,3 | 17,3 |
Liabilities and provisions for liabilities | 47,3 | 52,5 | 48 | -8,6 |
Net income from sale | 168,8 | 200,1 | 256,7 | 28,3 |
Short time liabilities | 32,4 | 40,1 | 33,7 | -15,9 |
Working assets | 320,8 | 479,6 | 513,3 | 7 |
Equity capital | 1007,3 | 1125,7 | 1109,2 | -1,5 |
Operating profit (EBIT) | 15,2 | 20,8 | 22,2 | 6,8 |
% | % | % | p.p. | |
Equity capital to total assets | 95,5 | 95,5 | 95,9 | 0,4 |
Gross profit margin | 53,5 | 63,3 | -3,4 | -66,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 70 | 73 | 48 | -25 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane